Health Canada issued a public advisory after a drug used to treat high blood pressure and chest pain has been recalled ...

Hims & Hers Health announced plans to expand to Canada in 2026. Hims will offer generic copies of semaglutide drugs in Canada ...

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

With measles outbreaks, avian influenza and syphilis and HIV on the rise, Canada needs to strengthen its disease surveillance ...

The federal government, industry, and provinces are seizing the crisis to try and build more stuff more quickly - "build, ...

Canada, he says, should double its funding to the Global Fund — the international organization that distributes funds ...

Canadians living with psychological illnesses continue to face exhausting uphill battles when applying for disability benefits.

Hims & Hers Health plans to expand into Canada, timing it with the new availability of the generic weight loss medication on the market for the first time.

Health Canada has issued a health product recall notice for a certain lot of Dr. Nutrition 360 Magnesium 200 mg capsules due to an incorrect non-medicinal ingredient.

The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as ...

Hims & Hers Health, Inc. (NYSE: HIMS) the leading digital health and wellness platform, today announced its plans to bring ...

68 per cent of Canadian households report use of air conditioning to beat the summer heat, says StatCan. The highest ...